GLIMEPIRIDE 1mg. IP

An antidiabetic drug used to lower raised blood sugar levels in type 2 diabetes mellitus patients. Increases the amount of insulin released by the pancreas to lower blood glucose. (Maria L.A.D. Lestari, 2011) Stimulates the pancreatic beta cells to release insulin. (Abdul Basit, 2012) Effectively reduces fasting plasma glucose, postprandial glucose, and glycosylated hemoglobin levels. (Abdul Basit, 2012) A valuable, cost-effective treatment option for managing type 2 diabetes mellitus. (Abdul Basit, 2012) Exhibits more potent glucose-lowering effects than glyburide. (Fahir Becić, 2003) Offers a lower risk of hypoglycemia and less weight gain compared to other sulfonylureas. (Abdul Basit, 2012) An alternative to other sulphonylureas in type 2 diabetes mellitus subjects not well controlled by diet alone. (H D Langtry, 1998) A beneficial therapy for the treatment of non-insulin-dependent (type II) diabetes mellitus. (Fahir Becić, 2003)